NDC 85237-1871 – Excedrin Migraine

Acetaminophen 250 mg/1; Aspirin 250 mg/1; Caffeine 65 mg/1 · Tablet, Film Coated · Oral

Human Otc Drug

Product NDC85237-1871

Product details

Brand name
Excedrin Migraine
Generic name
Acetaminophen, Aspirin, and Caffeine
Labeler
Select Consumer Group
Dosage form
Tablet, Film Coated
Route
Oral
Marketing category
NDA · NDA020802
Marketed since
September 30, 2020
Listing expires
December 31, 2027
Pharmacologic class
Central Nervous System Stimulant; Methylxanthine; Nonsteroidal Anti-inflammatory Drug; Platelet Aggregation Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Excedrin →

Package NDC codes (5)

Package NDCDescriptionSince
85237-1871-11 POUCH in 1 BLISTER PACK (85237-1871-1) / 2 TABLET, FILM COATED in 1 POUCHDec 24, 2025
85237-1871-22 POUCH in 1 BLISTER PACK (85237-1871-2) / 2 TABLET, FILM COATED in 1 POUCHDec 24, 2025
85237-1871-325 POUCH in 1 BOX, UNIT-DOSE (85237-1871-3) / 2 TABLET, FILM COATED in 1 POUCHDec 24, 2025
85237-1871-450 POUCH in 1 BOX, UNIT-DOSE (85237-1871-4) / 2 TABLET, FILM COATED in 1 POUCHDec 24, 2025
85237-1871-73 POUCH in 1 BLISTER PACK (85237-1871-7) / 2 TABLET, FILM COATED in 1 POUCH (85237-1871-0)Dec 24, 2025

Other Excedrin products